Subscribe To
Bioxcel therapeutics to report third quarter 2023 financial results on november 14, 2023
NEW HAVEN, Conn., Oct. 31, 2023 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intel...
October 31, 2023, 11:00 am
Neumora therapeutics to participate in upcoming conferences in november
WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining <...
October 30, 2023, 7:00 am
Medtronic stock is simply too cheap to ignore
Medtronic is a global medical technology company specializing in various medical devices. The company's revenues are well distributed among different ...
October 29, 2023, 5:07 am
Why abbvie stock fell today
AbbVie stock fell today despite easily exceeding estimates for its third quarter. Revenue declines across AbbVie's immunology, oncology, and aesthetic...
October 27, 2023, 3:06 pm
Seelos therapeutics to present a poster on sls-005 in alzheimer's disease at neuroscience 2023
-SLS-005 induces autophagy to reduce mutant protein aggregates, and is currently being studied in Alzheimer's disease, Huntington's disease, Amyotroph...
October 27, 2023, 8:11 am
Cognitive drivers of crypto investments: a neurofinance exploration of bitcoin
Amidst the dynamic evolution of the financial realm, an intriguing convergence of neuroscience and inve...
October 16, 2023, 4:29 am
Cerevel therapeutics to report third quarter 2023 financial results and business updates on wednesday, november 1, 2023
CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain...
October 13, 2023, 10:30 am
Cerevel therapeutics to report third quarter 2023 financial results and business updates on wednesday, november 1, 2023
CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain ...
October 13, 2023, 6:30 am
Cerevel therapeutics announces pricing of $450 million public offering of common stock
CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) — Cerevel Therapeutics Holdings, Inc. (Nasdaq: CERE), a company dedicated to unraveling the mysteri...
October 12, 2023, 2:45 am
Vigil neuroscience to present at jefferies inaugural biotech cns/neuro summit
WATERTOWN, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Vigil neuroscience, Inc. (Nasdaq: VIGL), a clinical...
October 5, 2023, 4:01 pm
Vigil neuroscience: interesting early data, wait for phase 2
Vigil neuroscience is developing medicines for neurodegenerative diseases by restoring microglial funct...
September 18, 2023, 2:38 pm
Neumora therapeutics announces pricing of initial public offering
WATERTOWN, Mass., Sept. 14, 2023 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc. (“Neumora”), a clinical-stage biopharmaceutical company redefinin...
September 15, 2023, 12:49 am
Helius medical technologies to present at the 2023 interdisciplinary association of functional neuroscience and rehabilitation conference
-- Presentation to educate on Portable Neuromodulation Stimulator (PoNS®) Therapy, highlighting the differentiation from other neuromodulation techno...
September 13, 2023, 7:05 am
Vigil neuroscience to present at 2023 morgan stanley global healthcare conference
WATERTOWN, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) — Vigil neuroscience, Inc. (Nasdaq: VIGL), a clinic...
September 8, 2023, 11:05 am
Promis neurosciences to present at the h.c. wainwright 25th annual global investment conference
TORONTO, Ontario and CAMBRIDGE, Massachusetts, Sept. 06, 2023 (GLOBE NEWSWIRE) -- ProMIS neurosciences ...
September 6, 2023, 12:18 pm
Abbvie: balance is everything
AbbVie's future growth depends on improving its balance of drugs offered, in contrast to its Humira-dependent first decade. Skyrizi and Rinvoq should ...
September 4, 2023, 1:12 am
Cerevance announces presentation at the 22nd society of chemical industry / royal society of chemistry medicinal chemistry symposium
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel, pre...
August 31, 2023, 12:30 pm
Eagle pharmaceuticals to present byfavo® (remimazolam) for injection abstract at prestigious society for neuroscience in anesthesiology and critical care (snacc) conference
-- Abstract compares relative effects on cognitive function following sedation with Byfavo (remimazolam) for injection versus midazolam -- Abstract co...
August 30, 2023, 6:50 am
Cerevel therapeutics to present at morgan stanley 21st annual global healthcare conference
CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain...
August 29, 2023, 6:30 am
Promoting excellence in mental healthcare: evoke neuroscience announces inaugural scholarship program
NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) — Evoke neuroscience, a leading provider of clinical brain h...
August 24, 2023, 7:09 pm